Benzodiazepines (BDZs) bind to the gamma sub-unit of the GABA-A receptor. Their binding causes an allosteric (structural) modification of the receptor that results in an increase in GABA A receptor activity. BDZs do not substitute for GABA, which bind at the alpha sub-unit, but increase the frequency of channel opening events which leads to an increase in chloride ion conductance and inhibition of the action potential.1
Related content
People with BD can experience residual symptoms that impact on functioning and QoL – these symptoms can benefit from an integrated approach to treatment
Patients with bipolar disorder and comorbidities are typically more complex cases than those without medical or psychiatric comorbidities
Bipolar disorder (BD) includes several disorders of emotion, thought, and energy, characterized by biphasic mood episodes of mania or hypomania and depression.